New eye surgery tech aims to prevent pressure spikes during cataract operations
NCT ID NCT07062107
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new adaptive fluidics system to traditional methods during cataract surgery. The goal is to keep eye pressure stable and reduce risks. About 320 adults with lens diseases will take part. The new system adjusts fluid flow in real time to avoid sudden pressure increases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
adaptive fluidics technology (a device that controls fluid pressure and flow during eye surgery)
What this could lead to
If successful, this technology could make cataract and other lens surgeries safer by reducing pressure spikes and complications.
What could go wrong
This is a relatively small, early-stage study comparing two surgical techniques. The new technology may not show significant benefits over the standard approach, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Affiliated Hospital, Zhejiang University School of Medicine,
Hangzhou, Zhejiang, 310009, China